A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy.

MLA

Santich, Brian H., et al. “A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-Step Pretargeted Radioimmunotherapy.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 27, no. 2, Jan. 2021, pp. 532–41. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-20-2150.

APA

Santich, B. H., Cheal, S. M., Ahmed, M., McDevitt, M. R., Ouerfelli, O., Yang, G., Veach, D. R., Fung, E. K., Patel, M., Burnes Vargas, D., Malik, A. A., Guo, H.-F., Zanzonico, P. B., Monette, S., Michel, A. O., Rudin, C. M., Larson, S. M., & Cheung, N. K. (2021). A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 27(2), 532–541. https://doi.org/10.1158/1078-0432.CCR-20-2150

Chicago

Santich, Brian H, Sarah M Cheal, Mahiuddin Ahmed, Michael R McDevitt, Ouathek Ouerfelli, Guangbin Yang, Darren R Veach, et al. 2021. “A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-Step Pretargeted Radioimmunotherapy.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 27 (2): 532–41. doi:10.1158/1078-0432.CCR-20-2150.